Endothelial Interferon Regulatory Factor 1 Cooperates with NF-κB as a Transcriptional Activator of Vascular Cell Adhesion Molecule 1
Open Access
- 1 May 1995
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 15 (5), 2558-2569
- https://doi.org/10.1128/mcb.15.5.2558
Abstract
Transcription of the vascular cell adhesion molecule 1 (VCAM-1) gene in endothelial cells is induced by lipopolysaccharide and the inflammatory cytokines interleukin-1 beta and tumor necrosis factor alpha (TNF-alpha). Previous studies have demonstrated that tandem binding sites for the inducible transcription factor NF-kappa B are necessary but not sufficient for full cytokine-mediated transcriptional activation. Herein, we demonstrate that full cytokine-induced accumulation of VCAM1 transcript requires protein synthesis. We report the definition of a functional regulatory element in the VCAM1 promoter interacting with the transcriptional activator interferon regulatory factor 1 (IRF-1). DNA-protein binding studies with endothelial nuclear extracts revealed that IRF-1 is cytokine inducible and binds specifically to a consensus sequence motif located 3' of the TATA element. We have identified heterodimeric p65 and p50 as the NF-kappa B species binding to the VCAM1 promoter in TNF-alpha-activated endothelial cells. Experiments with recombinant proteins showed that p50/p65 and high-mobility-group I(Y) protein cooperatively facilitated the binding of IRF-1 to the VCAM1 IRF binding site and that IRF-1 physically interacted with p50 and with high-mobility-group I(Y) protein. Transient transfection assay in endothelial cells showed that overexpressed IRF-1 resulted in superinduction of TNF-alpha-stimulated transcription. Site-directed mutations in the IRF binding element decreased TNF-alpha-induced activity and totally abolished superinduction. Cotransfection assays in P19 embryonal carcinoma cells revealed that IRF-1 synergized with p50/p65 NF-kappa B to activate the VCAM1 promoter or heterologous promoter constructs bearing isolated VCAM1 NF-kappa B and IRF binding motifs. Cytokine inducibility of VCAM1 in endothelial cells utilizes the interaction of heterodimeric p50/p65 proteins with IRF-1.Keywords
This publication has 70 references indexed in Scilit:
- Requirement for Transcription Factor IRF-1 in NO Synthase Induction in MacrophagesScience, 1994
- Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elementsCell, 1993
- The interferon‐stimulable response elements of two human genes detect overlapping sets of transcription factorsEuropean Journal of Biochemistry, 1993
- NF-κB Subunit Regulation in Nontransformed CD4 + T LymphocytesScience, 1992
- Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversityCell, 1991
- A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture.The Journal of cell biology, 1991
- The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB functionCell, 1990
- Adhesion of Human B Cells to Germinal Centers in Vitro Involves VLA-4 and INCAM-110Science, 1990
- Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elementsCell, 1988
- Not more than 117 base pairs of 5′-flanking sequence are required for inducible expression of a human IFN-α geneNature, 1983